Pharmaceutical Archives - CED Foundation

Flavonoid Shampoo is Chemical Free and Nourishing

April 16, 2020 Cannabis, Flavonoids, Pharmaceutical

A Completely Polyherbal Conditioning and Antioxidant Shampoo- A Phytochemical Study and Pharmaceutical Evaluation

In Summary

Researchers have recently developed a conditioning shampoo using flavonoids and a foaming agent that nourishes hair and provides antimicrobial effects. Generic storebought shampoos have been found to have detrimental effects on hair follicles and scalp health, often stripping them of their natural oils and causing dryness and irritation. The leaves of Salix babylonica L., Ziziphus spina-christi L. (Willd), and Glycyrrhiza glabra rhizomes were used to make an extract rich in flavonoids and other phenolic compounds. The extract was altered until the ideal microbial effect was found and then combined with a foaming agent, forming the natural shampoo. Future research should continue to develop a line of all-natural cosmetic products for those who are sensitive or wish to avoid chemicals.

This piece reflects the current trend of the beauty industry and the apparent future of cosmetics as all-natural products. Researchers and estheticians will likely create products that appease trend-followers desire to endorse all-natural products while also enjoying the effects of the products that have been enhanced by modern science. The cannabis industry, will all of the benefits provided by cannabinoids, flavonoids, and terpenes, would do well to capitalize on the rapidly growing and fiercely loyal beauty community by promoting natural products that are as effective as they are trendy.

The study is available for review below, or in the CED Foundation Literature Archive.

A-Completely-Polyherbal-Conditioning-and-Antioxidant-Shampoo-A-Phytochemical-Study-and-Pharmaceutical-Evaluation Download

The study is available for review or download here

View more studies like this in the CED Foundation Archive

To explore related information, click the keywords below:

Medical Cannabis for Adults Over 50

December 22, 2019 Adult, Adverse Effects, Aging, Arthritis, Behavior change, Business of Cannabis, Cannabis, Cannabis Education, Cannabis Science, Case Study, Cognition, Dementia, Depression, Elderly, Future Medicine, Geriatrics, Mental Health, Pain, Pharmaceutical, Retail Cannabis, Seniors

In Summary:

As with all elements of the aging process, the human endocannabinoid system loses tone over time. Whether it is a reduction in the numbers of cannabinoid receptors or a slow waning of the machinery used to create the signaling molecules that bind to the receptors or the natural senescence of the system that supports all of these normal signaling processes, the fact remains that adults over 50 are best-suited for external support for the endocannabinoid system.

Indeed, the average age at dispensaries is surprising to most who are not familiar with the modern medical cannabis arena. Baby Boomers, perhaps more than any other age group, tend to dominate the medical cannabis dispensaries. This is no new phenomenon, however. Through the ages, across cultures and around the globe, cannabis has been consumed primarily by older adults. Whether by tribe elders, wise councilmen, spiritual leaders, or the educated elite, cannabis has been an integral part of human aging for as long as we have recorded history.

Here, a review out of Israel followed at 184 patients over 65 (average age was 81.2) beginning cannabis treatment. 63.6% were female. “After six months of treatment, 58.1% were still using cannabis. Of these patients, 33.6% reported adverse events, the most common of which were dizziness (12.1%) and sleepiness and fatigue (11.2%). Of the respondents, 84.8% reported some degree of improvement in their general condition.”

Appropriately, the authors advise caution for older adults related to those adults who may be consuming multiple pharmaceuticals, for potential medication interaction effects, as well as nervous system impairment, and increased cardiovascular risk for those who may quire the concern. Wisely, they recommend that “Medical cannabis should still be considered carefully and individually for each patient after a risk-benefit analysis and followed by frequent monitoring for efficacy and adverse events.”

Dr. Caplan and the #MDTake:

At CED Clinic, we have long seen that the average age of medical patients is over 50. Whether for concerns related to sleep, pain, mental or physical health, it seems as though Baby Boomers have either weathered enough politics to have developed a healthy cynicism for the misinformation campaigns of the 1930s and 1970s, or they have direct or indirect experience with cannabis to have learned of its safety and efficacy. Either way, it is quickly reclaiming its historical place in the care of older adults, although oddly… it seems to be a demographic skipped over by the marketing systems of most establishments in the cannabis arena, at least for now.

direction of action for cannabis treatments

bar of significant improvement with cannabis

View this review (yellow link) or download:

Medical Cannabis for Older Patients—Treatment Protocol and Initial Results Download

This paper is also stored here: http://bit.ly/2QbJ6yE inside the CED Foundation Archive

To explore related information, click the keywords below:

Flavonoids Proven to be Safe and Effective Treatment for Chronic Venous Disease

November 29, 2019 Blood-Levels, Cannabinoids, Cannabis Education, Cannabis Science, Flavonoids, Pharmaceutical, Women in Cannabis

Recommendations for the medical management of chronic venous disease- The role of Micronized Purified Flavonoid Fraction (MPFF)

In Summary:

A recent review has affirmed that treating chronic venous disease with Micronized Purified Flavonoid Fraction (MPFF) therapy is safe and effective. After reviewing 250 papers, the authors have found a large body of supportive evidence that the MPFF treatment, known as Diosmiplex, is effective for healing venous ulcers on its own or in combination with compression therapy. Diosmiplex, the only MPFF prescribed in the United States, as of 2017, is derived from orange rinds and favorable among patients due to its high safety rating.

Dr. Caplan and the #MDTake:

Flavonoids are one of the categories of natural compounds produced in nature, including within the innate production system of the cannabis plant. Several patients have reported using strong cannabis topical agents to help venous insufficiency and disease, including conditions such as varicose veins, phlebitis, and post-surgical venous incompetence.